KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Return on Equity: 2016-2025

Historic Return on Equity for Medpace Holdings (MEDP) over the last 9 years, with Sep 2025 value amounting to 1.86%.

  • Medpace Holdings' Return on Equity rose 141.00% to 1.86% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.86%, marking a year-over-year increase of 141.00%. This contributed to the annual value of 0.58% for FY2024, which is 1.00% down from last year.
  • Latest data reveals that Medpace Holdings reported Return on Equity of 1.86% as of Q3 2025, which was up 70.15% from 1.09% recorded in Q2 2025.
  • Medpace Holdings' 5-year Return on Equity high stood at 1.86% for Q3 2025, and its period low was 0.19% during Q1 2021.
  • In the last 3 years, Medpace Holdings' Return on Equity had a median value of 0.59% in 2025 and averaged 0.73%.
  • Per our database at Business Quant, Medpace Holdings' Return on Equity fell by 25bps in 2024 and then surged by 141bps in 2025.
  • Over the past 5 years, Medpace Holdings' Return on Equity (Quarterly) stood at 0.20% in 2021, then soared by 47bps to 0.67% in 2022, then fell by 12bps to 0.55% in 2023, then decreased by 8bps to 0.47% in 2024, then spiked by 141bps to 1.86% in 2025.
  • Its Return on Equity stands at 1.86% for Q3 2025, versus 1.09% for Q2 2025 and 0.59% for Q1 2025.